VANI Earnings Date: Nov 12, 2026 (Estimated) — Vivani Medical, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is VANI's next earnings date?
Vivani Medical, Inc. (VANI) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.07.
How did VANI do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Vivani Medical, Inc. posted EPS of -$0.07 versus the -$0.08 estimate, a beat of 12.5%. Revenue was $0. The stock's 1-day post-earnings move was +4.5%.
How much does VANI stock move after earnings?
VANI beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.4% (up or down) in the day after earnings.
About Vivani Medical, Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.08 | -0.07 | +12.50% | $0 | ✅ Beat | +4.48% | +5.22% | -5.97% |
| 2026-05-13 | Q1 2026 | -0.08 | -0.08 | +0.00% | $0 | ➖ Inline | +3.45% | +2.59% | -5.17% |
| 2026-03-26 | Q4 2025 | -0.09 | -0.09 | +0.00% | $0 | ➖ Inline | -5.56% | +0.00% | +28.70% |
| 2025-11-13 | Q3 2025 | -0.11 | -0.11 | +0.00% | $0 | ➖ Inline | -11.44% | -10.46% | -11.76% |
| 2025-08-13 | Q2 2025 | -0.10 | -0.12 | -20.00% | $0 | ❌ Miss | +0.79% | -3.17% | -3.97% |
| 2025-03-31 | Q4 2024 | -0.10 | -0.11 | -10.00% | $0 | ❌ Miss | -5.41% | -13.51% | -7.21% |
| 2024-11-13 | Q3 2024 | -0.13 | -0.11 | +15.38% | $0 | ✅ Beat | +11.20% | +3.20% | +4.00% |
| 2024-08-13 | Q2 2024 | -0.12 | -0.10 | +16.67% | $0 | ✅ Beat | +8.62% | +18.97% | +6.90% |
Showing last 8 quarters.